Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes

Autor: Ander Regueiro, Guillem Caldentey, Marc Izquierdo, Victoria Martin-Yuste, Andrea Fernandez-Valledor, Xavier Freixa, Manel Sabaté, Gustavo Jiménez-Brítez, Juan Betuel Ivey-Miranda, M. Farrero, Sara Vazquez, Ignacio Ferreira-González, Eduardo Flores-Umanzor, Pedro L. Cepas-Guillén
Rok vydání: 2020
Předmět:
Zdroj: Catheterization and Cardiovascular Interventions. 97:376-383
ISSN: 1522-726X
1522-1946
Popis: BACKGROUND Chronic total occlusion (CTO) is common in patients with diabetes mellitus. Data on the long-term outcomes after treatment of CTOs in this high-risk population are scarce. AIM To compare the long-term clinical outcomes of CTO revascularization either by coronary artery bypass graft (CABG) or successful percutaneous coronary intervention (PCI) versus optimal medical treatment (MT) alone in patients with diabetes. METHODS AND RESULTS A total of 538 consecutive patients with diabetes and at least one CTO were identified from 2010 to 2014 in our center. In the present analysis, patients were stratified according to the CTO treatment strategy that was selected. MT was selected in 61% of patients whereas revascularization in the remaining 39%. Patients undergoing revascularization were younger, had higher left ventricular ejection fraction (LVEF), lower ACEF score, and more positive myocardial ischemia detection results compared to the MT group (p
Databáze: OpenAIRE